Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral Sclerosis
04/12/2025 13:44
Dec 4 (Reuters) - Neurosense Therapeutics Ltd NRSN.O: NEUROSENSE THERAPEUTICS LTD - RESUMING REGULATORY ADVANCEMENT IN CANADA FOR PRIMEC IN AMYOTROPHIC LATERAL SCLEROSIS NEUROSENSE THERAPEUTICS LTD - ANTICIPATES POTENTIAL NDS SUBMISSION BY MID-2026 Source text: [ID:n0001213900-25-118083] Further company coverage: NRSN.O ((Reuters.Briefs@thomsonreuters.com;))